Lee Ainslie - Maverick Capital Ltd
Holding/activity history for Abiomed Inc (ABMD)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2022 Q4 | 0 | 0.00 | Sell 100.00% | 0.01 | SEC | ||
| 2022 Q3 | 1,007 | 0.01 | Buy | 0.01 | $245.28 | $247,000 | SEC |
| 2022 Q2 | 0 | 0.00 | Sell 100.00% | <0.01 | SEC | ||
| 2022 Q1 | 792 | <0.01 | Add 165.77% | <0.01 | $330.81 | $262,000 | SEC |
| 2021 Q4 | 298 | <0.01 | Reduce 94.43% | 0.02 | $359.06 | $107,000 | SEC |
| 2021 Q3 | 5,347 | 0.02 | Reduce 31.93% | <0.01 | $325.60 | $1,741,000 | SEC |
| 2021 Q2 | 7,855 | 0.02 | Add 171.89% | 0.01 | $312.16 | $2,452,000 | SEC |
| 2021 Q1 | 2,889 | 0.01 | Reduce 52.23% | 0.02 | $318.80 | $921,000 | SEC |
| 2020 Q4 | 6,048 | 0.03 | Add 136.81% | 0.02 | $324.24 | $1,961,000 | SEC |
| 2020 Q3 | 2,554 | 0.01 | Reduce 74.39% | 0.04 | $277.21 | $708,000 | SEC |
| 2020 Q2 | 9,973 | 0.05 | Buy | 0.05 | $241.55 | $2,409,000 | SEC |
| 2018 Q1 | 0 | 0.00 | Sell 100.00% | 0.08 | SEC | ||
| 2017 Q4 | 32,580 | 0.08 | Buy | 0.08 | $187.42 | $6,106,000 | SEC |